The Analyst Landscape: 17 Takes On BioNTech
Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, ...
in.investing.com on MSN5h
Denmark shares lower at close of trade; OMX Copenhagen 20 down 0.14%
Denmark equities were lower at the close on Thursday, as losses in the Copenhagen Real Estate, OMX Copenhagen Personal & Household Goods PI and Copenhagen Health Care sectors led shares lower. At the ...
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.14%
Denmark stocks were lower after the close on Thursday, as losses in the Real Estate, Personal & Household Goods and ...
Assetmark Inc. Has $2.01 Million Stock Position in Genmab A/S (NASDAQ:GMAB)
Assetmark Inc. boosted its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 16.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 82,629 shares of ...
Genmab price target lowered to DKK 2,250 from DKK 2,500 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Genmab (GMAB) to DKK 2,250 from DKK 2,500 and keeps a Buy rating on the shares.